348 related articles for article (PubMed ID: 29935114)
1. Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning.
Cima LN; Martin SC; Lambrescu IM; Stejereanu L; Zaharia C; Colita A; Fica S
J Pediatr Endocrinol Metab; 2018 Aug; 31(8):869-878. PubMed ID: 29935114
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
[TBL] [Abstract][Full Text] [Related]
3. Thyroid Disorders Following Hematopoietic Stem Cell Transplantation in Childhood: Impact of Conditioning Regimen on Thyroid Dysfunction, Volume Changes, and Occurrence of Nodules.
Cattoni A; Molinari S; Gaiero A; De Lorenzo P; Fichera G; Riva B; Di Marco S; Tommesani C; Mariani E; Medici F; Pagni F; Nicolosi ML; Fraschini D; Napolitano S; Rovelli A; Biondi A; Valsecchi MG; Balduzzi A
Transplant Cell Ther; 2022 Aug; 28(8):506.e1-506.e12. PubMed ID: 35660063
[TBL] [Abstract][Full Text] [Related]
4. Adult testicular volume predicts spermatogenetic recovery after allogeneic HSCT in childhood and adolescence.
Wilhelmsson M; Vatanen A; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Pediatr Blood Cancer; 2014 Jun; 61(6):1094-100. PubMed ID: 24851267
[TBL] [Abstract][Full Text] [Related]
5. Subclinical hypothyroidism in children and adolescents after hematopoietic stem cells transplantation without irradiation.
Milenković T; Vujić D; Vuković R; Zečević Ž; Soldatović I; Mitrović K; Todorović S; Zdravković D
Vojnosanit Pregl; 2014 Dec; 71(12):1123-7. PubMed ID: 25639000
[TBL] [Abstract][Full Text] [Related]
6. Comparison of conditioning regimens for autologous stem cell transplantation in children with acute myeloid leukemia: A nationwide retrospective study in Japan.
Sakaguchi H; Muramatsu H; Hasegawa D; Kudo K; Ishida H; Yoshida N; Koh K; Noguchi M; Shiba N; Tokimasa S; Fukuda T; Goto H; Miyamura T; Nakazawa Y; Hashii Y; Inoue M; Atsuta Y;
Pediatr Blood Cancer; 2019 Jan; 66(1):e27459. PubMed ID: 30270523
[TBL] [Abstract][Full Text] [Related]
7. Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases.
Somali M; Mpatakoias V; Avramides A; Sakellari I; Kaloyannidis P; Smias C; Anagnostopoulos A; Kourtis A; Rousso D; Panidis D; Vagenakis A
Gynecol Endocrinol; 2005 Jul; 21(1):18-26. PubMed ID: 16048797
[TBL] [Abstract][Full Text] [Related]
8. Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation.
Bizzarri C; Pinto RM; Ciccone S; Brescia LP; Locatelli F; Cappa M
Pediatr Blood Cancer; 2015 Sep; 62(9):1650-5. PubMed ID: 26017459
[TBL] [Abstract][Full Text] [Related]
9. Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning.
Gherman RF; Ewald S; Ihorst G; Strüßmann T; Zeiser R; Wäsch R; Bertz H; Stolz D; Duyster J; Finke J; Marks R; Engelhardt M; Duque-Afonso J
Eur J Haematol; 2024 Mar; 112(3):350-359. PubMed ID: 37823328
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
[TBL] [Abstract][Full Text] [Related]
11. A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies.
Yang T; Lin Q; Ren J; Chen P; Yuan X; Luo X; Liu T; Zheng J; Zheng Z; Zheng X; Chen X; Zhang L; Zheng H; Chen Z; Hua X; Le S; Li J; Chen Z; Hu J
Oncotarget; 2016 Nov; 7(48):78773-78786. PubMed ID: 27705929
[TBL] [Abstract][Full Text] [Related]
12. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence.
Vatanen A; Wilhelmsson M; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Eur J Endocrinol; 2014 Feb; 170(2):211-8. PubMed ID: 24179099
[TBL] [Abstract][Full Text] [Related]
13. Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.
Kashyap A; Wingard J; Cagnoni P; Roy J; Tarantolo S; Hu W; Blume K; Niland J; Palmer JM; Vaughan W; Fernandez H; Champlin R; Forman S; Andersson BS
Biol Blood Marrow Transplant; 2002; 8(9):493-500. PubMed ID: 12374454
[TBL] [Abstract][Full Text] [Related]
14. [Effect of BU and CY versus TBI and CY as conditioning regimens on the efficacy of haploidentical stem cell transplantation in patients with hematologic malignancy].
Shao Q; Han D; Liu D; Zheng X; Dong L; Wang Z; Ding L; Yan H; Wang H; Duan L
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):505-10. PubMed ID: 24985173
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
[TBL] [Abstract][Full Text] [Related]
16. Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes.
Farhadfar N; Stan MN; Shah P; Sonawane V; Hefazi MT; Murthy HS; Zou F; Sican X; Hashmi SK
Bone Marrow Transplant; 2018 Aug; 53(8):977-982. PubMed ID: 29410547
[TBL] [Abstract][Full Text] [Related]
17. Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience.
Hamidieh AA; Alimoghaddam K; Jahani M; Bahar B; Mousavi SA; Iravani M; Behfar M; Jalali A; Jalili M; Hamdi A; Ghavamzadeh A
J Pediatr Hematol Oncol; 2013 Aug; 35(6):e239-45. PubMed ID: 23042019
[TBL] [Abstract][Full Text] [Related]
18. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis.
Yamamoto W; Andou T; Itabashi M; Koyama S; Ishii Y; Numata A; Motohashi K; Hagihara M; Matsumoto K; Fujisawa S
Intern Med; 2016; 55(13):1721-7. PubMed ID: 27374671
[TBL] [Abstract][Full Text] [Related]
20. Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
Ingram W; Devereux S; Das-Gupta EP; Russell NH; Haynes AP; Byrne JL; Shaw BE; McMillan A; Gonzalez J; Ho A; Mufti GJ; Pagliuca A
Br J Haematol; 2008 Apr; 141(2):235-43. PubMed ID: 18318762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
